Assignee
ONCOUR PHARMA INC
US·2 granted patents·7 pending applications·2 citations·filing 2018–2023
Top patents by PatentIndex Score
9 records- 0182US2024000830A1Immune-modifying nanoparticles for the treatment of inflammatory diseasesONCOUR PHARMA INC·Filed 2023·Application pending·0 cites
- 0280US11045492B2Immune-modifying nanoparticles for the treatment of inflammatory diseasesONCOUR PHARMA INC·Filed 2018·Granted Jun 29, 2021·1 cites·28 claims
- 0378US2024245719A1Modified immune-modulating particlesONCOUR PHARMA INC·Filed 2023·Application pending·0 cites
- 0472US11020424B2Modified immune-modulating particlesONCOUR PHARMA INC·Filed 2018·Granted Jun 1, 2021·1 cites·9 claims
- 0553US2024398852A1Negatively charged particles for the treatment of inflammation-related burn injuriesONCOUR PHARMA INC·Filed 2022·Application pending·0 cites
- 0650US2023190895A1Negatively charged particles for the treatment of cytokine storm syndrome (css) and acute respiratory distress syndrome (ards)ONCOUR PHARMA INC·Filed 2021·Application pending·0 cites
- 0750US2025170066A1Treatment of solid tumors with negatively charged particlesONCOUR PHARMA INC·Filed 2023·Application pending·0 cites
- 0847US2021290661A1Immune modifying particles for the treatment of cancerONCOUR PHARMA INC·Filed 2019·Application pending·0 cites
- 0941US2022257768A1Treatment of immune evasive tumorsONCOUR PHARMA INC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →